Effectiveness of long-term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary

A Ramunni1, L F Morrone, G Baldassarre

  • 1Division of Nephrology, Department of Internal and Public Medicine, University of Bari, Bari, Italy. a.ramunni@libero.it

Insights

This case study shows HELP apheresis effectively lowers LDL-Cholesterol in a patient with familial hypercholesterolemia and coronary heart disease. The treatment reduced arterial calcifications and stenoses, preventing further cardiac events.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high LDL-Cholesterol (LDL) levels, significantly increasing cardiovascular disease risk.
  • Aggressive lipid-lowering therapy is crucial for managing high-risk hypercholesterolemic patients to reduce mortality and cardiovascular events.

Observation:

  • A 51-year-old woman with heterozygous FH and coronary heart disease (CHD) presented with worsening angina.
  • Despite statin therapy for ten years, her LDL-Cholesterol remained elevated, and coronary angiography revealed significant coronary artery disease.
  • Following coronary bypass surgery, she underwent six years of HELP apheresis combined with statins.

Findings:

  • HELP apheresis significantly reduced total cholesterol (TCHO), LDL-Cholesterol, and fibrinogen levels.
  • Post-treatment measurements showed a substantial decrease in TCHO, LDL, and fibrinogen, with a slight decrease in HDL.
  • Follow-up coronary angiography demonstrated the disappearance of calcifications and stable or reduced stenoses, with no further clinical manifestations of CHD.

Implications:

  • HELP apheresis is a valuable therapeutic option for patients with FH and CHD who struggle to lower LDL-Cholesterol effectively.
  • This treatment can lead to regression of atherosclerotic lesions and prevent recurrent cardiovascular events in high-risk individuals.
  • The findings support the clinical benefit of HELP apheresis for managing severe hypercholesterolemia and associated premature coronary sclerosis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...